ConductScience.org, home

Paper2073095

Comparative in vitro activities of amoxicillin-clavulanic acid, cefuroxime, cephalexin, and cephalothin against trimethoprim-resistant Escherichia coli isolated from stools of children attending day-care centers.

Singh KV and 3 others. Antimicrob Agents Chemother, 1990. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Comparative in vitro activities of amoxicillin-clavulanic acid, cefuroxime, cephalexin, and cephalothin against trimethoprim-resistant Escherichia coli isolated from stools of children attending day-care centers. Papers, record 2073095. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2073095

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative in vitro activities of amoxicillin-clavulanic acid, cefuroxime, cephalexin, and cephalothin against trimethoprim-resistant Escherichia coli isolated from stools of children attending day-care centers.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1990
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.4
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Singh KVK V
2Reves RRR R
3Pickering LKL K
4Murray BEB E

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Child Day Care CentersMajor topic
Escherichia coliMajor topic
Trimethoprim ResistanceMajor topic
Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Cefuroxime
Cephalexin
Cephalothin
Child, Preschool
Clavulanic Acids
Drug Therapy, Combination
Feces
Humans
Infant
Microbial Sensitivity Tests
Plasmids

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11259407Cefuroxime, a new cephalosporin antibiotic: activity in vitro.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1259407PubMed
2248268Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/248268PubMed
3475369In vitro of cefotaxime against cephalothin-resistant clinical isolates.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/475369PubMed
47009583Rapid procedure for detection and isolation of large and small plasmids.J Bacteriol1981https://conductscience.org/library/papers/7009583PubMed
57177896Diarrhea in day care centers.Pediatr Infect Dis1982https://conductscience.org/library/papers/7177896PubMed
62201257Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2201257PubMed
73522088
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.
Diagn Microbiol Infect Dis1986https://conductscience.org/library/papers/3522088PubMed
83535051Intrafamilial spreading of Escherichia coli resistant to trimethoprim.Scand J Infect Dis1986https://conductscience.org/library/papers/3535051PubMed
93309072Children with trimethoprim- and ampicillin-resistant fecal Escherichia coli in day care centers.J Infect Dis1987https://conductscience.org/library/papers/3309072PubMed
103262045Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.Chemotherapy1988https://conductscience.org/library/papers/3262045PubMed
112671132Problems and mechanisms of antimicrobial resistance.Infect Dis Clin North Am1989https://conductscience.org/library/papers/2671132PubMed
126330662Infectious diseases and child day care.Pediatrics1984https://conductscience.org/library/papers/6330662PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
38457194Cefazolin as a predictor of urinary cephalosporin activity in indicated Enterobacterales.J Clin Microbiol2024https://conductscience.org/library/papers/38457194PubMed
27456093Faecal carriage of antibiotic resistant Escherichia coli in asymptomatic children and associations with primary care antibiotic prescribing: a systematic review and meta-analysis.BMC Infect Dis2016https://conductscience.org/library/papers/27456093PubMed
8799689Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.Drugs1996https://conductscience.org/library/papers/8799689PubMed
8405150The prevalence of antimicrobial resistance in human faecal flora in South Africa.Epidemiol Infect1993https://conductscience.org/library/papers/8405150PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2073095

GET https://conductscience.org/api/papers/v1/2073095/authors